DCF — SOUTHERN PLAINS MED CTR OF GARVIN CO
Enterprise Value: $-44.1M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-44.1M
Enterprise Value
$-14.0M
PV of Cash Flows
$-30.1M
PV of Terminal Value
$-48.5M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $29.2M | $-2.7M | -9.0% | $-4.0M | $-3.6M |
| Year 2 | $30.0M | $-2.5M | -8.0% | $-3.8M | $-3.1M |
| Year 3 | $30.9M | $-2.3M | -7.0% | $-3.6M | $-2.7M |
| Year 4 | $31.9M | $-2.2M | -7.0% | $-3.5M | $-2.4M |
| Year 5 | $32.8M | $-2.2M | -7.0% | $-3.6M | $-2.2M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-44.1M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$28.3M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.09832675676130045
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5